Avivagen says ‘numerous’ parties interested in M&A talks with struggling firm
Troubled Ottawa-based life sciences firm Avivagen says it has received “numerous responses” from companies that are interested in potentially acquiring all or part of its
Avivagen says ‘numerous’ parties interested in M&A talks with struggling firm
Troubled Ottawa-based life sciences firm Avivagen says it has received “numerous responses” from companies that are interested in potentially acquiring all or part of its
Deals will see Ottawa-based company ship a total of about six tonnes of its immune-boosting compound to poultry, livestock and dairy producers in the three
Avivagen bets on OxC-beta to unlock global livestock supplement markets
An Ottawa life sciences firm has the green light to test the product in the world’s most populous country as it looks to reverse years
Ottawa-based Avivagen sees Q2 revenues jump
Life sciences firm produces supplements aimed at replacing antibiotics in cattle feed.
Ottawa bioscience firm Avivagen set to unveil immune-boosting supplements for humans
Fortified by $7.5 million in fresh funding, company is hoping a new version of its flagship product designed for people will help it finally achieve
Ottawa-based bioscience firm Avivagen lists shares on U.S. venture exchange
An Ottawa-based firm that has landed millions of dollars in funding to develop an alternative to antibiotic-based livestock feed has begun trading on a U.S.
Ottawa-based life sciences firm Avivagen lands $1.25M private placement
An Ottawa-based company is refilling its trough of funding as it develops an alternative to antibiotic-based livestock feed
Ottawa biotech firm Avivagen’s revenues slip on mistimed sales cycle
Local biotech firm Avivagen hit a snag in revenues this past quarter even as the firm continues to secure regulatory approvals for its alternative to
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored